OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mesangial Cells and Renal Fibrosis
Jinghong Zhao
Advances in experimental medicine and biology (2019), pp. 165-194
Closed Access | Times Cited: 85
Jinghong Zhao
Advances in experimental medicine and biology (2019), pp. 165-194
Closed Access | Times Cited: 85
Showing 1-25 of 85 citing articles:
Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets
Allison B. Reiss, Berlin Jacob, Aarij Zubair, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1881-1881
Open Access | Times Cited: 17
Allison B. Reiss, Berlin Jacob, Aarij Zubair, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1881-1881
Open Access | Times Cited: 17
Autophagy and Renal Fibrosis
Shan Liang, Yun-Shan Wu, Dong-Yi Li, et al.
Aging and Disease (2022) Vol. 13, Iss. 3, pp. 712-712
Open Access | Times Cited: 53
Shan Liang, Yun-Shan Wu, Dong-Yi Li, et al.
Aging and Disease (2022) Vol. 13, Iss. 3, pp. 712-712
Open Access | Times Cited: 53
Flavonoids in Treatment of Chronic Kidney Disease
Yiling Cao, Jihong Lin, Hans‐Peter Hammes, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2365-2365
Open Access | Times Cited: 52
Yiling Cao, Jihong Lin, Hans‐Peter Hammes, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2365-2365
Open Access | Times Cited: 52
The Wnt Signaling Pathway in Diabetic Nephropathy
Haiying Wang, Ran Zhang, Xinjie Wu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 51
Haiying Wang, Ran Zhang, Xinjie Wu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 51
tRF3-IleAAT reduced extracellular matrix synthesis in diabetic kidney disease mice by targeting ZNF281 and inhibiting ferroptosis
Yunyang Qiao, Jialing Ji, Wei-ling Hou, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 5, pp. 1032-1043
Closed Access | Times Cited: 10
Yunyang Qiao, Jialing Ji, Wei-ling Hou, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 5, pp. 1032-1043
Closed Access | Times Cited: 10
Nobiletin: a potential erythropoietin receptor activator protects renal cells against hypoxia
Na Liu, Yuzhuo Sun, Jieyun Liu, et al.
APOPTOSIS (2025)
Closed Access | Times Cited: 1
Na Liu, Yuzhuo Sun, Jieyun Liu, et al.
APOPTOSIS (2025)
Closed Access | Times Cited: 1
Roles and action mechanisms of WNT4 in cell differentiation and human diseases: a review
Quanlong Zhang, Yan Pan, Jingjing Ji, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 48
Quanlong Zhang, Yan Pan, Jingjing Ji, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 48
Interplay between extracellular matrix components and cellular and molecular mechanisms in kidney fibrosis
Sandra Rayego‐Mateos, Sofía Campillo, Raúl R. Rodrigues-Díez, et al.
Clinical Science (2021) Vol. 135, Iss. 16, pp. 1999-2029
Closed Access | Times Cited: 47
Sandra Rayego‐Mateos, Sofía Campillo, Raúl R. Rodrigues-Díez, et al.
Clinical Science (2021) Vol. 135, Iss. 16, pp. 1999-2029
Closed Access | Times Cited: 47
Targeted Drug Delivery Systems for Kidney Diseases
Xiaohan Huang, Yanhong Ma, Yang Yang Li, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 44
Xiaohan Huang, Yanhong Ma, Yang Yang Li, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 44
Astaxanthin: A promising therapeutic agent for organ fibrosis
Ké Li, Wenhong Wang, Weihua Xiao
Pharmacological Research (2023) Vol. 188, pp. 106657-106657
Open Access | Times Cited: 17
Ké Li, Wenhong Wang, Weihua Xiao
Pharmacological Research (2023) Vol. 188, pp. 106657-106657
Open Access | Times Cited: 17
Macrophages communicate with mesangial cells through the CXCL12/DPP4 axis in lupus nephritis pathogenesis
Weiwei Li, Chun Yao, Haixia Guo, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 6
Weiwei Li, Chun Yao, Haixia Guo, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 6
LncRNA lnc‐ISG20 promotes renal fibrosis in diabetic nephropathy by inducing AKT phosphorylation through miR‐486‐5p/NFAT5
Yurui Duan, Bao‐Ping Chen, Fang Chen, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 11, pp. 4922-4937
Open Access | Times Cited: 33
Yurui Duan, Bao‐Ping Chen, Fang Chen, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 11, pp. 4922-4937
Open Access | Times Cited: 33
Role of Nanotechnology and Their Perspectives in the Treatment of Kidney Diseases
J. P. Jose Merlin, Xiaogang Li
Frontiers in Genetics (2022) Vol. 12
Open Access | Times Cited: 26
J. P. Jose Merlin, Xiaogang Li
Frontiers in Genetics (2022) Vol. 12
Open Access | Times Cited: 26
In silico prediction and experimental validation to reveal the protective mechanism of Puerarin against excessive extracellular matrix accumulation through inhibiting ferroptosis in diabetic nephropathy
Biyu Hou, Peng Ma, Xinyu Yang, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117281-117281
Closed Access | Times Cited: 13
Biyu Hou, Peng Ma, Xinyu Yang, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117281-117281
Closed Access | Times Cited: 13
Lysosomal dysfunction–induced autophagic stress in diabetic kidney disease
Hui Juan Zheng, Xueqin Zhang, Jing Guo, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 15, pp. 8276-8290
Open Access | Times Cited: 33
Hui Juan Zheng, Xueqin Zhang, Jing Guo, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 15, pp. 8276-8290
Open Access | Times Cited: 33
The extract of Polygala fallax Hemsl. slows the progression of diabetic nephropathy by targeting TLR4 anti-inflammation and MMP-2/9-mediated anti-fibrosis in vitro
Min Hui Wang, Xinyan Liu, Zelong Wang, et al.
Phytomedicine (2022) Vol. 104, pp. 154251-154251
Closed Access | Times Cited: 19
Min Hui Wang, Xinyan Liu, Zelong Wang, et al.
Phytomedicine (2022) Vol. 104, pp. 154251-154251
Closed Access | Times Cited: 19
Hirudin in the Treatment of Chronic Kidney Disease
Sai-Ji Liu, Yiling Cao, Chun Zhang
Molecules (2024) Vol. 29, Iss. 5, pp. 1029-1029
Open Access | Times Cited: 4
Sai-Ji Liu, Yiling Cao, Chun Zhang
Molecules (2024) Vol. 29, Iss. 5, pp. 1029-1029
Open Access | Times Cited: 4
Fructus arctii mitigates diabetic nephropathy via the Apoh/PPAR-γ pathway
Na Zhang, Anhui Chen, Yuwei Dong, et al.
Molecular Immunology (2025) Vol. 181, pp. 18-28
Closed Access
Na Zhang, Anhui Chen, Yuwei Dong, et al.
Molecular Immunology (2025) Vol. 181, pp. 18-28
Closed Access
Mechanism of LncRNA-MiRNA in Renal Intrinsic Cells of Diabetic Kidney Disease and Potential Therapeutic Direction
Xiyue Tian, Min Zhou, Jingbo Zhang, et al.
DNA and Cell Biology (2025)
Closed Access
Xiyue Tian, Min Zhou, Jingbo Zhang, et al.
DNA and Cell Biology (2025)
Closed Access
RETRACTED: LNCRNA CDKN2B-AS1 regulates mesangial cell proliferation and extracellular matrix accumulation via miR-424-5p/HMGA2 axis
Yang Li, Linlin Zheng, Denggao Huang, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 121, pp. 109622-109622
Open Access | Times Cited: 35
Yang Li, Linlin Zheng, Denggao Huang, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 121, pp. 109622-109622
Open Access | Times Cited: 35
Advances in kidney-targeted drug delivery systems
Zhong Chen, Haisheng Peng, Changmei Zhang
International Journal of Pharmaceutics (2020) Vol. 587, pp. 119679-119679
Closed Access | Times Cited: 30
Zhong Chen, Haisheng Peng, Changmei Zhang
International Journal of Pharmaceutics (2020) Vol. 587, pp. 119679-119679
Closed Access | Times Cited: 30
Mesangial cell: A hub in lupus nephritis
Mengdi Liu, Lei Zhang, Yixin Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Mengdi Liu, Lei Zhang, Yixin Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cells
Donghee Kim, Gayoung Nam, Eunhui Seo, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 17
Donghee Kim, Gayoung Nam, Eunhui Seo, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 17
USP25 inhibits renal fibrosis by regulating TGFβ-SMAD signaling pathway in Ang II-induced hypertensive mice
Ying‐Yong Zhao, Xi Chen, Yimin Lin, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 6, pp. 166713-166713
Open Access | Times Cited: 10
Ying‐Yong Zhao, Xi Chen, Yimin Lin, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 6, pp. 166713-166713
Open Access | Times Cited: 10
Astragaloside IV attenuates high glucose‐induced NF‐κB ‐mediated inflammation through activation of PI3K /AKT‐ERK ‐dependent Nrf2/ARE signaling pathway in glomerular mesangial cells
Xue Su, Hengjiang Guo, Yuying Zhou, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 9, pp. 4133-4148
Closed Access | Times Cited: 10
Xue Su, Hengjiang Guo, Yuying Zhou, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 9, pp. 4133-4148
Closed Access | Times Cited: 10
